← Back to the feed

National

VA research: a new way to deliver autoimmune treatment, and virtual pain care for rural women veterans

Developing Confirmed

Oct. 2, 2026 — VA researchers in Baltimore developed a microparticle that releases the anti-inflammatory compound itaconate inside cells and reduced inflammation-driving proteins in a mouse model of multiple sclerosis, the VA said. A separate eight-week virtual pain program for 31 rural women veterans was found beneficial by nearly all participants.

The wall: Results come from a mouse study and a 31-person pilot; neither is a treatment approval.

Tier: Confirmed (full text of VA research release)

Sources

This newsfeed was produced and brought to you by Temporal Data Dynamics Technology. For more information, visit temporaldatadynamics.com.

Inquiries

GTR is serious AI for serious professionals. Every answer generates its own dated reference trail, and the trail shows what no single record could.

Tell us what you're working on, and we'll be in touch.

Required

Enter "Unaffiliated" if none.

Role

We use these details to understand your request and prepare our response.